Dequilla, Jesus M.
HRN: 18-20-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
MUPIROCIN 2%, 15G (TUBE)
03/28/2023
04/03/2023
TOPICAL
Depends
Bid
Infected Wounds
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes